The Patent Finder

Multimmune GmbH

Also on record
Records under this name other than the patents Multimmune GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 6 of 6 · Back to Multimmune GmbH

PatentTitleStatus Expires Confidence
US 7,700,737Therapeutic and diagnostic anti-Hsp70 antibodies
Term ended
Term ended Jan 19, 2026 · From the USPTO record
Term endedTerm ended Jan 19, 2026From the USPTO record
US 8,440,188Therapeutic and diagnostic anti-HSP70 antibodies
Term ended
Term ended Dec 6, 2024 · From the USPTO record
Term endedTerm ended Dec 6, 2024From the USPTO record
US 7,517,948HSP70 Peptide Stimulating Natural Killer (NK) Cell Activity and Uses Thereof
Term ended
Term ended Nov 10, 2022 · High confidence
Term endedTerm ended Nov 10, 2022High confidence
US 7,745,399HSP70 Peptide Stimulating Natural Killer (NK) Cell Activity and Uses Thereof
Lapsed on the fee record
Ended Jun 29, 2018 · High confidence
Lapsed on the fee recordEnded Jun 29, 2018High confidence
US 7,722,863Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells
Lapsed on the fee record
Ended May 25, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 25, 2018From the USPTO record
US 7,943,740Compositions and methods for the treatment and diagnosis of neoplastic and infectious diseases
Lapsed on the fee record
Ended May 17, 2015 · From the USPTO record
Lapsed on the fee recordEnded May 17, 2015From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited